Dokentera - Company finances
|
EUR
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | - | - | - | - | 44,850 | 255,205 | 254,080 |
| Profit before tax | - | - | - | - | - | - | 151,378 |
| Net profit | 0 | 0 | 0 | 0 | 37,714 | 130,554 | 142,294 |
| Equity | 2,800 | 2,896 | 2,896 | 2,896 | 40,610 | 3,364 | 57,422 |
| Liabilities | 0 | 0 | 0 | 0 | 4,583 | 123,922 | 16,748 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 1,446 | 6,303 |
| Current assets | 2,800 | 2,896 | 2,896 | 2,896 | 45,193 | 125,840 | 67,867 |
| Total assets | 2,800 | 2,896 | 2,896 | 2,896 | 45,193 | 127,286 | 74,170 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 246 | 54,161 | 94,157 |
| Social insurance contributions | - | - | - | - | - | - | 7,706 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | - | - | - | - | +469.0% | -0.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | 0.0% | 0.0% | 0.0% | 83.5% | 102.6% | 191.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | 0.0% | 0.0% | 0.0% | 92.9% | 3880.9% | 247.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | 84.1% | 51.2% | 56.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | 59.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 0.1 | 36.8 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | 44,850 | 133,148 | 66,282 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Dokentera - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-08-19 | 2024-08-20 | 0.10 |
| 2024-07-24 | 2024-08-04 | 0.10 |
Dokentera - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-03-06 | 2025-03-06 | 4409.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Dokentera, UAB (code 303287836) is a Private Limited Liability Company active in other engineering activities and related technical consultancy. In the latest financial year, 2025, the company generated revenue of €254.1K and net profit of €142.3K, resulting in a 56.0% profit margin. Revenue was broadly stable year on year, edging down by 0.4%, while the two-year comparison still shows very strong growth of 466.5%. The business therefore moved from a smaller scale in 2023, when revenue was €44.9K and net profit €37.7K, to a much larger turnover base in 2024 and 2025. On the balance sheet, total assets stood at €74.2K at the end of 2025, with equity of €57.4K and liabilities of €16.7K, indicating a solid equity position. The equity ratio was 77.4% and debt-to-equity 0.29, while asset turnover reached 3.43x. Revenue per employee was €84.7K and profit per employee €47.4K, pointing to strong operating productivity.